Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently

Author:

Abidov Musa,Sokolova Ksenia,Danilova Irina,Baykenova MadinaORCID,Gette Irina,Mychlynina ElenaORCID,Aydin Ozgur BurcinORCID,Gurol Ali Osman,Yilmaz M. Temel

Abstract

Insulin-positive (+) cells (IPCs), detected in multiple organs, are of great interest as a probable alternative to ameliorate pancreatic beta-cells dysfunction and insulin deficiency in diabetes. Liver is a potential source of IPCs due to it common embryological origin with pancreas. We previously demonstrated the presence of IPCs in the liver of healthy and diabetic rats, but detailed description and analysis of the factors, which potentially can induced ectopic hepatic expression of insulin in type 1 (T1D) and type 2 diabetes (T2D), were not performed. In present study we evaluate mass of hepatic IPCs in the rat models of T1D and T2D and discuss factors, which may stimulate it generation: glycaemia, organ injury, involving of hepatic stem/progenitor cell compartment, expression of transcription factors and inflammation. Quantity of IPCs in the liver was up by 1.7-fold in rats with T1D and 10-fold in T2D compared to non-diabetic (ND) rats. We concluded that ectopic hepatic expression of insulin gene is activated by combined action of a number of factors, with inflammation playing a decision role.

Funder

IIP UB RAS: Institute Immunology and Physiology Ural Branch Russian Academy of Science

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference80 articles.

1. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040;K. Ogurtsova;Diabetes Res Clin Pract,2017

2. American Diabetes Association. Diagnosis and classification of diabetes mellitus;Diabetes Care,2009

3. Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance;B. Saberzadeh-Ardestani;Cell J,2018

4. Insulin resistance and type 2 diabetes;R. Taylor;Diabetes,2012

5. The time is right for a new classification system for diabetes: rationale and implications of the β-cell–centric classification schema;S.S. Schwartz;Diabetes Care,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3